http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 13 Aug 2026 16:32:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Miluna+Acquisition+Corp+++For%3A+Jun+30/26921914.html si-local-file:///var/storage/secattach/20260813/26921914.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Miluna+Acquisition+Corp+++For%3A+Jun+30/26921914.html Thu, 13 Aug 2026 16:32:00 -0400 MMTX MMTXU http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Miluna+Acquisition+Corp+++For%3A+Jun+30/26921914.html si-local-file:///var/storage/secattach/20260813/26921914.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Miluna+Acquisition+Corp+++For%3A+Jun+30/26921914.html Thu, 13 Aug 2026 16:32:00 -0400 MMTX MMTXU http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Miluna+Acquisition+Corp++++++++++++++++Filed+by%3A+MIZUHO+FINANCIAL+GROUP+INC/26916082.html si-local-file:///var/storage/secattach/20260813/26916082.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Miluna+Acquisition+Corp++++++++++++++++Filed+by%3A+MIZUHO+FINANCIAL+GROUP+INC/26916082.html Thu, 13 Aug 2026 06:51:00 -0400 MMTX MMTXU http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Miluna+Acquisition+Corp++++++++++++++++Filed+by%3A+MIZUHO+FINANCIAL+GROUP+INC/26916082.html si-local-file:///var/storage/secattach/20260813/26916082.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Miluna+Acquisition+Corp++++++++++++++++Filed+by%3A+MIZUHO+FINANCIAL+GROUP+INC/26916082.html Thu, 13 Aug 2026 06:51:00 -0400 MMTX MMTXU http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 12, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. <person>John Krakauer</person> has joined the Company as a strategic advisor to support its next phase of growth in <location value="LC/us" idsrc="xmltag.org" >the United States</location>.</p> <p><i>"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," </i>said <person>Zach Henderson</person>, CEO of <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span>.<i> "As we scale in <location value="LC/us" http://www.streetinsider.com/PRNewswire/MindMaze+Therapeutics+Appoints+Prof.+John+W.+Krakauer+as+Strategic+Advisor/26907758.html Wed, 12 Aug 2026 01:39:00 -0400 A.17351412 A.22771047 A.37199449 MMTX MMTX O.01271198 O.07451918 O.13558813 O.20042566 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Completes+Organizational+Simplification+and+Provides+Update+on+Neuro.io+Equity+Financing/26892915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 10, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today provided updates on two previously announced initiatives supporting its strategic priorities in neurology: the completion of its <a target="_blank" href="https://mindmazetherapeutics.com/mindmaze-therapeutics-announces-non-core-asset-sale-and-organizational-simplification/" target="_blank" rel="nofollow">organizational simplification</a> initiative, and the implementation of its <a target="_blank" href="https://mindmazetherapeutics.com/mindmaze-therapeutics-announces-chf-8-0-million-strategic-equity-financing/" target="_blank" rel="nofollow"><money>CHF 8.0 million</money> strategic equity financing</a> with Neuro.io <span>Group SA</span> (Neuro.io). Together, these initiatives further support the execution of the Company's <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial priorities and the advancement http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Completes+Organizational+Simplification+and+Provides+Update+on+Neuro.io+Equity+Financing/26892915.html Mon, 10 Aug 2026 01:28:00 -0400 MMTX MMTX O.07451918 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Completes+Organizational+Simplification+and+Provides+Update+on+Neuro.io+Equity+Financing/26892915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 10, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today provided updates on two previously announced initiatives supporting its strategic priorities in neurology: the completion of its <a target="_blank" href="https://mindmazetherapeutics.com/mindmaze-therapeutics-announces-non-core-asset-sale-and-organizational-simplification/" target="_blank" rel="nofollow">organizational simplification</a> initiative, and the implementation of its <a target="_blank" href="https://mindmazetherapeutics.com/mindmaze-therapeutics-announces-chf-8-0-million-strategic-equity-financing/" target="_blank" rel="nofollow"><money>CHF 8.0 million</money> strategic equity financing</a> with Neuro.io <span>Group SA</span> (Neuro.io). Together, these initiatives further support the execution of the Company's <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial priorities and the advancement http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Completes+Organizational+Simplification+and+Provides+Update+on+Neuro.io+Equity+Financing/26892915.html Mon, 10 Aug 2026 01:28:00 -0400 MMTX MMTX O.07451918 http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Completes+Organizational+Simplification+and+Provides+Update+on+Neuro.io+Equity+Financing/26892915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ch..geneva" idsrc="xmltag.org" >GENEVA</location></span>, <span class="legendSpanClass"><chron>Aug. 10, 2026</chron></span> /PRNewswire/ -- <span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics Holding SA</span> (SIX: MMTX) (<span value="Swiss:MMTX" idsrc="xmltag.org" >MindMaze Therapeutics</span> or the Company), a global leader in scalable precision neurotherapeutics, today provided updates on two previously announced initiatives supporting its strategic priorities in neurology: the completion of its <a target="_blank" href="https://mindmazetherapeutics.com/mindmaze-therapeutics-announces-non-core-asset-sale-and-organizational-simplification/" target="_blank" rel="nofollow">organizational simplification</a> initiative, and the implementation of its <a target="_blank" href="https://mindmazetherapeutics.com/mindmaze-therapeutics-announces-chf-8-0-million-strategic-equity-financing/" target="_blank" rel="nofollow"><money>CHF 8.0 million</money> strategic equity financing</a> with Neuro.io <span>Group SA</span> (Neuro.io). Together, these initiatives further support the execution of the Company's <location value="LC/us" idsrc="xmltag.org" >U.S</location>. commercial priorities and the advancement http://www.streetinsider.com/Press+Releases/MindMaze+Therapeutics+Completes+Organizational+Simplification+and+Provides+Update+on+Neuro.io+Equity+Financing/26892915.html Mon, 10 Aug 2026 01:28:00 -0400 MMTX MMTX O.07451918